{"id":1613,"date":"2026-09-14T22:41:16","date_gmt":"2026-09-14T22:41:16","guid":{"rendered":"https:\/\/simplelifescience.com\/peptide-synthesis-for-cros-complete-guide\/"},"modified":"2026-09-14T22:41:16","modified_gmt":"2026-09-14T22:41:16","slug":"peptide-synthesis-for-cros-complete-guide","status":"publish","type":"post","link":"https:\/\/simplelifescience.com\/es\/peptide-synthesis-for-cros-complete-guide\/","title":{"rendered":"Peptide Synthesis Services for CROs: 2026 Guide"},"content":{"rendered":"<style>.pseo-content { font-size: 17px; line-height: 1.7; color: inherit; }\n.pseo-content h2 { font-size: 1.6em; margin-top: 1.8em; margin-bottom: 0.6em; line-height: 1.3; color: inherit; }\n.pseo-content h3 { font-size: 1.25em; margin-top: 1.5em; margin-bottom: 0.4em; line-height: 1.35; color: inherit; }\n.pseo-content h4 { color: inherit; }\n.pseo-content p { margin: 0 0 1em; }\n.pseo-content ul, .pseo-content ol { margin: 0 0 1em 1.4em; padding: 0; }\n.pseo-content li { margin: 0.3em 0; }\n.pseo-content strong { font-weight: 600; }\n.pseo-content blockquote { margin: 1.2em 0; padding: 0.6em 1em; border-left: 3px solid color-mix(in srgb, currentColor 30%, transparent); background: color-mix(in srgb, currentColor 4%, transparent); color: inherit; }\n.pseo-content a { text-decoration: underline; }<\/p>\n<p>.pseo-content .pseo-table-wrap { overflow-x: auto; margin: 1.4em 0; -webkit-overflow-scrolling: touch; }\n.pseo-content table { width: 100% !important; border-collapse: collapse !important; table-layout: auto !important; font-size: 0.96em; }\n.pseo-content table th,\n.pseo-content table td {\n  padding: 10px 12px !important;\n  border-bottom: 1px solid color-mix(in srgb, currentColor 14%, transparent) !important;\n  border-left: none !important;\n  border-right: none !important;\n  vertical-align: top !important;\n  text-align: left !important;\n  word-break: break-word !important;\n  overflow-wrap: anywhere !important;\n  white-space: normal !important;\n}\n.pseo-content table th {\n  background: color-mix(in srgb, currentColor 6%, transparent) !important;\n  color: inherit !important;\n  font-weight: 600 !important;\n  border-top: 1px solid color-mix(in srgb, currentColor 14%, transparent) !important;\n}\n.pseo-content table tr:last-child td { border-bottom: 1px solid color-mix(in srgb, currentColor 14%, transparent) !important; }<\/style>\n<div class=\"pseo-content\">\n<p>Peptide synthesis services for CROs are outsourced sequence design, production, purification, and analytical characterization workflows that let contract research organizations deliver sponsor-defined peptide specifications without carrying in-house synthesis capacity. A CRO&#39;s requirements differ from an academic lab&#39;s: every batch has to trace back to a written scope, a sponsor protocol, and an audit-ready lot record, and production has to flex from milligram-scale feasibility work to multi-gram supply inside a single project timeline.<\/p>\n<div class=\"pseo-tldr\" style=\"display:flow-root;clear:both;margin:32px 0;padding:24px 28px;border:1px solid;border-color:rgba(128,128,128,0.35);border-color:color-mix(in srgb, currentColor 14%, transparent);border-left:3px solid;border-left-color:rgba(128,128,128,0.6);border-left-color:color-mix(in srgb, currentColor 30%, transparent);border-radius:12px;background-color:rgba(128,128,128,0.06);background-color:color-mix(in srgb, currentColor 4%, transparent);max-width:100%;\">\n<div class=\"pseo-tldr-label\" style=\"font-size:11px;font-weight:700;letter-spacing:0.12em;text-transform:uppercase;color:rgba(128,128,128,0.9);color:color-mix(in srgb, currentColor 55%, transparent);margin-bottom:12px;\">TL;DR<\/div>\n<ul style=\"float:none;margin:0;padding-left:20px;list-style:disc;\">\n<li style=\"float:none;margin:8px 0;font-size:15px;line-height:1.6;color:inherit;\">Peptide synthesis services for CROs succeed or fail on lot-level documentation, not on advertised turnaround alone.<\/li>\n<li style=\"float:none;margin:8px 0;font-size:15px;line-height:1.6;color:inherit;\">Scale flexibility matters more than headline price \u2014 sponsors move from screening quantities to production runs inside one contract.<\/li>\n<li style=\"float:none;margin:8px 0;font-size:15px;line-height:1.6;color:inherit;\">Analytical acceptance criteria (identity by mass spec, purity by HPLC) must be agreed with the sponsor before synthesis starts, not after.<\/li>\n<li style=\"float:none;margin:8px 0;font-size:15px;line-height:1.6;color:inherit;\">Simple Life Science supports custom peptide and small-molecule synthesis with defined specifications and lot documentation for research-only use.<\/li>\n<\/ul>\n<\/div>\n<h2>Why peptide synthesis services matter for CROs<\/h2>\n<p>A CRO does not buy a peptide. It buys a documented process it can hand to a sponsor&#39;s quality or regulatory reviewer. That means the vendor selection decision is really a documentation decision: does the synthesis partner produce a certificate of analysis that matches the sponsor&#39;s protocol, and does the lot record survive an audit two years later?<\/p>\n<p>Most CRO peptide programs run in phases \u2014 a feasibility batch, a repeat batch for a second study arm, then a scaled batch for extended work. Each phase has its own acceptance criteria, and a vendor that cannot repeat a specification exactly, batch to batch, forces the CRO to re-validate its own study design. That repeat cost is the real reason CROs standardize on one or two synthesis partners instead of shopping every order.<\/p>\n<h3>Define the sponsor&#39;s specification and acceptance criteria<\/h3>\n<p>Before any synthesis order goes out, the CRO needs the specification in writing \u2014 sequence, modifications, purity threshold, quantity, and format (salt form, lyophilized versus solution).<\/p>\n<ul>\n<li>Confirm sequence and any non-standard modifications (acetylation, amidation, non-natural residues) in writing with the sponsor<\/li>\n<li>Set the purity acceptance threshold explicitly; \u226595% purity by HPLC is a common baseline for research-grade peptide batches<\/li>\n<li>Specify identity confirmation method (typically mass spectrometry) as part of the acceptance criteria, not as an optional add-on<\/li>\n<li>Record quantity and format requirements (lyophilized powder, salt form, counter-ion) before quoting<\/li>\n<li>Flag any study-specific stability or storage requirement the vendor needs to accommodate<\/li>\n<\/ul>\n<h3>Select synthesis scale and chemistry route<\/h3>\n<p>Scale drives method choice. A 5 mg feasibility batch and a 2-gram production batch are different jobs even when the sequence is identical.<\/p>\n<ul>\n<li>Match chemistry route (solid-phase, hybrid, or fragment condensation) to sequence length and modification complexity<\/li>\n<li>Confirm the vendor can run both screening-scale and scale-up batches without switching processes mid-project<\/li>\n<li>Review <a href=\"https:\/\/simplelifescience.com\/peptide-synthesis-services-ranked-by-production-scale\/\">peptide synthesis services ranked by production scale<\/a> before committing a multi-phase contract to one vendor<\/li>\n<li>Ask how a scale change affects lead time and whether the acceptance criteria carry over unchanged<\/li>\n<li>Confirm capacity for difficult sequences (high hydrophobicity, aggregation-prone segments) before quoting a full program<\/li>\n<\/ul>\n<h3>Plan purification and analytical testing<\/h3>\n<p>Purification method and analytical review have to be locked before production, not negotiated after the batch is made.<\/p>\n<ul>\n<li>Define the purification method (reverse-phase HPLC is standard for research peptides) and target purity band<\/li>\n<li>Specify which analytical tests accompany every lot: identity, purity, and \u2014 where relevant \u2014 counter-ion content or residual solvent<\/li>\n<li>Compare <a href=\"https:\/\/blog.simplelifescience.com\/best-analytical-testing-services-for-peptide-purity-in\">analytical testing services for peptide purity<\/a> to confirm the method matches what the sponsor protocol requires<\/li>\n<li>Require a certificate of analysis with every lot, not on request<\/li>\n<li>Set a retest trigger (time-based or event-based) for batches held in inventory across a multi-arm study<\/li>\n<\/ul>\n<h3>Qualify a synthesis partner for CRO project pipelines<\/h3>\n<p>Once scope, scale, and acceptance criteria are defined, the CRO is choosing a partner it can reuse across projects \u2014 not a one-time vendor.<\/p>\n<ul>\n<li>Request a written scope document per project, not a generic quote<\/li>\n<li>Confirm the vendor issues lot-level documentation as standard, including batch-specific analytical data<\/li>\n<li>Check <a href=\"https:\/\/simplelifescience.com\/custom-peptide-synthesis-services-ranked-by-price-in\/\">custom peptide synthesis services ranked by price<\/a> to understand where different vendor tiers sit before a full RFP<\/li>\n<li>Ask directly whether the vendor supports both research peptide orders and small-molecule synthesis, since many CRO programs need both<\/li>\n<li>Simple Life Science works from a defined scope through synthesis, purification, and analytical characterization for research-only projects, which keeps documentation consistent across a CRO&#39;s project queue<\/li>\n<\/ul>\n<h3>Verify identity and purity before release<\/h3>\n<p>Release decisions belong to the CRO, not the synthesis vendor \u2014 verification is a separate step from production.<\/p>\n<ul>\n<li>Cross-check the certificate of analysis against the original written specification line by line<\/li>\n<li>Confirm identity data (mass spec result) matches expected mass within the agreed tolerance<\/li>\n<li>Confirm purity data meets the pre-agreed threshold, not a vendor default<\/li>\n<li>Hold release until documentation is complete; a missing analytical field is a reason to delay, not to waive<\/li>\n<li>Log any deviation and its resolution as part of the project record<\/li>\n<\/ul>\n<h3>Document lot records for audit readiness<\/h3>\n<p>Sponsor audits happen months or years after a batch ships. The record has to stand on its own.<\/p>\n<ul>\n<li>Retain the written scope, certificate of analysis, and any correspondence on specification changes in one project file<\/li>\n<li>Confirm lot numbers on internal records match the vendor&#39;s lot numbers exactly<\/li>\n<li>Store analytical raw data references (chromatograms, spectra) alongside the summary certificate where the vendor provides them<\/li>\n<li>Track which sponsor protocol version each batch was produced against<\/li>\n<li>Keep documentation retention aligned to the sponsor&#39;s study timeline, not just the CRO&#39;s internal policy<\/li>\n<\/ul>\n<h3>Manage retesting and reorder timing across projects<\/h3>\n<p>Multi-project CRO queues mean the same peptide may sit in inventory while a second study arm is scheduled.<\/p>\n<ul>\n<li>Set a retest interval for stored lyophilized inventory rather than assuming indefinite stability<\/li>\n<li>Confirm reconstitution and storage guidance with the vendor before a batch is pulled for a new study arm<\/li>\n<li>Reorder against the original specification rather than a new quote, to avoid lot-to-lot drift<\/li>\n<li>Flag any sequence or scale change to the vendor explicitly \u2014 a reorder is not automatically identical to the original batch<\/li>\n<\/ul>\n<div class=\"pseo-cta\" style=\"display:flow-root;clear:both;margin:32px 0;padding:28px;border:1px solid;border-color:rgba(128,128,128,0.35);border-color:color-mix(in srgb, currentColor 14%, transparent);border-radius:12px;background-color:rgba(128,128,128,0.06);background-color:color-mix(in srgb, currentColor 4%, transparent);max-width:100%;text-align:center;\">\n<p style=\"margin:0;font-size:20px;font-weight:700;line-height:1.35;letter-spacing:-0.01em;color:inherit;\">Submit a scientific brief for review<\/p>\n<p style=\"margin:8px 0 0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">Send your specification for synthesis and documentation review.<\/p>\n<div style=\"display:flex;flex-wrap:wrap;justify-content:center;gap:10px;margin-top:18px;\"><a class=\"pseo-cta-button\" href=\"https:\/\/simplelifescience.com\/\" style=\"display:inline-block;padding:14px 28px;border:1px solid;border-color:rgba(128,128,128,0.9);border-color:color-mix(in srgb, currentColor 55%, transparent);border-radius:10px;background-color:rgba(128,128,128,0.12);background-color:color-mix(in srgb, currentColor 10%, transparent);font-size:16px;font-weight:700;line-height:1.4;color:inherit;text-decoration:none;\">Submit a brief<\/a><\/div>\n<\/div>\n<h2>Comparison: synthesis options for CRO programs<\/h2>\n<div class=\"pseo-table-wrap\">\n<table>\n<thead>\n<tr>\n<th>Option<\/th>\n<th>Best for<\/th>\n<th>Key limitation<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>In-house synthesis line<\/td>\n<td>CROs with sustained, high-volume peptide programs and capital budget<\/td>\n<td>Capex and validation timeline before first batch<\/td>\n<\/tr>\n<tr>\n<td>Academic core facility<\/td>\n<td>Early feasibility screening on a single sequence<\/td>\n<td>Limited lot documentation depth for sponsor audits<\/td>\n<\/tr>\n<tr>\n<td>Boutique custom synthesis vendor (e.g., Simple Life Science)<\/td>\n<td>Project-based sponsor work needing lot-level documentation across scales<\/td>\n<td>Capacity ceiling on very large single-batch runs<\/td>\n<\/tr>\n<tr>\n<td>Large CDMO<\/td>\n<td>Late-stage programs needing full regulatory-grade support<\/td>\n<td>Longer lead times and higher minimum commitments<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p><strong>Verdict: for project-based CRO work that needs to move between screening scale and scale-up without losing documentation continuity, a boutique custom synthesis vendor with defined lot records is the practical fit; reserve large CDMOs for late-stage programs with regulatory support requirements.<\/strong><\/p>\n<h2>Common mistakes CROs make with peptide synthesis vendors<\/h2>\n<ul>\n<li><strong>Treating vendors as interchangeable.<\/strong> A lower quote with thinner documentation costs more in re-validation time than it saves.<\/li>\n<li><strong>Locking acceptance criteria after production starts.<\/strong> Purity and identity thresholds have to be agreed in the written scope, not renegotiated on delivery.<\/li>\n<li><strong>Underestimating retest timing.<\/strong> Inventory held between study arms needs a retest trigger, not an assumption of indefinite stability.<\/li>\n<li><strong>Choosing on turnaround alone.<\/strong> A fast quote with no analytical method disclosure is a documentation gap waiting to surface at audit.<\/li>\n<li><strong>Ignoring scale flexibility.<\/strong> Committing a multi-phase contract to a vendor that only handles one production scale forces a mid-project vendor switch.<\/li>\n<\/ul>\n<h2>FAQ<\/h2>\n<div class=\"pseo-faq\" style=\"display:flow-root;clear:both;margin:32px 0;padding:8px 28px;border:1px solid;border-color:rgba(128,128,128,0.35);border-color:color-mix(in srgb, currentColor 14%, transparent);border-radius:12px;background-color:rgba(128,128,128,0.06);background-color:color-mix(in srgb, currentColor 4%, transparent);max-width:100%;\">\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">What documentation should a CRO expect with every peptide batch?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">A CRO should expect a certificate of analysis covering identity (typically mass spectrometry) and purity (typically HPLC) for every lot, tied to a written scope document. Lot numbers on the certificate should match the vendor&#8217;s internal batch record exactly.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">Is peptide synthesis for CROs different from synthesis for academic labs?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">Yes \u2014 CRO work is tied to sponsor protocols and audit trails, so documentation depth and batch-to-batch consistency matter more than for exploratory academic screening. Academic core facilities often skip the lot-level detail CRO sponsors require.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">What purity threshold is standard for research peptides in 2026?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">A purity threshold of 95% or higher by HPLC is a common baseline for research-grade peptide batches in 2026, though the sponsor protocol sets the exact figure per project. The acceptance criterion should be written into the specification before synthesis starts.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">Can one vendor handle both screening-scale and production-scale batches?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">Some vendors support both, which avoids switching processes mid-project. Confirm scale flexibility and whether acceptance criteria carry over unchanged before committing a multi-phase contract to one supplier.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">How often should stored peptide inventory be retested?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">There is no universal interval \u2014 it depends on storage condition, formulation, and the sponsor&#8217;s study timeline. Set a retest trigger as part of the project plan rather than assuming indefinite shelf stability.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">Does Simple Life Science support custom peptide synthesis for CRO projects?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">Simple Life Science works from a defined scope through synthesis, purification, and analytical characterization for research-only projects, producing lot-level documentation suited to CRO project files.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">What is the difference between bulk peptide API and custom synthesis for a CRO?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">Bulk peptide API supplies an existing, defined sequence at scale, while custom synthesis covers sequence design and production for a project-specific peptide or small molecule. CRO programs often need both across a study lifecycle.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">Why does scale flexibility matter more than price for CRO synthesis vendors?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">CRO contracts frequently move from a milligram-scale feasibility batch to a gram-scale production batch inside one program. A vendor that cannot repeat the same specification across scales forces a mid-project vendor switch and re-validation cost.<\/p>\n<\/div>\n<\/div>\n<h2>One last thing<\/h2>\n<p>The single biggest documentation gap in CRO peptide programs is not missing purity data \u2014 it is a mismatch between the sponsor&#39;s protocol version and the lot record on file. A batch produced against an earlier draft of the specification, without a documented change log, is the finding an auditor catches first. Build the change log into the project file from the first batch, not after a second study arm is added in 2026.<\/p>\n<h2>Related guides<\/h2>\n<ul>\n<li><a href=\"https:\/\/blog.simplelifescience.com\/best-small-molecule-synthesis-companies-for-research-labs\">Small molecule synthesis companies for research labs<\/a><\/li>\n<li><a href=\"https:\/\/blog.simplelifescience.com\/peptide-analytical-services-ranked-by-turnaround-time\">Peptide analytical services ranked by turnaround time<\/a><\/li>\n<\/ul>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What documentation should a CRO expect with every peptide batch?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"A CRO should expect a certificate of analysis covering identity (typically mass spectrometry) and purity (typically HPLC) for every lot, tied to a written scope document. Lot numbers on the certificate should match the vendor's internal batch record exactly.\"}},{\"@type\":\"Question\",\"name\":\"Is peptide synthesis for CROs different from synthesis for academic labs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes \u2014 CRO work is tied to sponsor protocols and audit trails, so documentation depth and batch-to-batch consistency matter more than for exploratory academic screening. Academic core facilities often skip the lot-level detail CRO sponsors require.\"}},{\"@type\":\"Question\",\"name\":\"What purity threshold is standard for research peptides in 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"A purity threshold of 95% or higher by HPLC is a common baseline for research-grade peptide batches in 2026, though the sponsor protocol sets the exact figure per project. The acceptance criterion should be written into the specification before synthesis starts.\"}},{\"@type\":\"Question\",\"name\":\"Can one vendor handle both screening-scale and production-scale batches?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Some vendors support both, which avoids switching processes mid-project. Confirm scale flexibility and whether acceptance criteria carry over unchanged before committing a multi-phase contract to one supplier.\"}},{\"@type\":\"Question\",\"name\":\"How often should stored peptide inventory be retested?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"There is no universal interval \u2014 it depends on storage condition, formulation, and the sponsor's study timeline. Set a retest trigger as part of the project plan rather than assuming indefinite shelf stability.\"}},{\"@type\":\"Question\",\"name\":\"Does Simple Life Science support custom peptide synthesis for CRO projects?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Simple Life Science works from a defined scope through synthesis, purification, and analytical characterization for research-only projects, producing lot-level documentation suited to CRO project files.\"}},{\"@type\":\"Question\",\"name\":\"What is the difference between bulk peptide API and custom synthesis for a CRO?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Bulk peptide API supplies an existing, defined sequence at scale, while custom synthesis covers sequence design and production for a project-specific peptide or small molecule. CRO programs often need both across a study lifecycle.\"}},{\"@type\":\"Question\",\"name\":\"Why does scale flexibility matter more than price for CRO synthesis vendors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"CRO contracts frequently move from a milligram-scale feasibility batch to a gram-scale production batch inside one program. A vendor that cannot repeat the same specification across scales forces a mid-project vendor switch and re-validation cost.\"}}]}<\/script>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Peptide synthesis services for CROs in 2026: define specs, select scale, verify purity, and document lots. Compare vendor options with clear best-for verdicts.<\/p>","protected":false},"author":1,"featured_media":1612,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":""},"categories":[79],"tags":[],"class_list":["post-1613","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-quality-documentation"],"_links":{"self":[{"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/posts\/1613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/comments?post=1613"}],"version-history":[{"count":0,"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/posts\/1613\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/media\/1612"}],"wp:attachment":[{"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/media?parent=1613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/categories?post=1613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/tags?post=1613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}